Program
JADE101
A development code.
Its studies are mostly in Glomerulonephritis, IGA, led by Jade Biosciences.
Furthest: phase 3, since Oct 22, 20264 company-led studies, 3 open or runningNext primary completion: May 2027 (phase 1)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Jade Biosciences | 43 open or running | phase 3since Oct 22, 2026 | Jun 27, 2025 | May 2027phase 1 · NCT07525947 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jun 27, 2025First study: phase 1 study in Healthy VolunteersFirst studyNCT07059312 · 32 enrolled · New Zealand
- Apr 6, 2026Phase 1 study in Healthy Volunteers (HV)NCT07525947 · 40 planned · United States
- Apr 14, 2026Phase 2 study in Glomerulonephritis, IGANCT07541287 · 30 planned · United States, Australia, New Zealand and more
- Oct 22, 2026Phase 3 study in Glomerulonephritis, IGAPhase 3 reachedNCT07902817 · 480 planned · United States
Ahead
- May 2027Primary completion: phase 1 study in Healthy Volunteers (HV)NCT07525947
- Jan 2029Primary completion: phase 2 study in Glomerulonephritis, IGANCT07541287
- Jun 2029Primary completion: phase 3 study in Glomerulonephritis, IGANCT07902817
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07902817Glomerulonephritis, IGA · United States | 3 | Recruiting | Jun 2029 | 480 |
| NCT07541287Glomerulonephritis, IGA · United States, Australia, New Zealand and more | 2 | Recruiting | Jan 2029 | 30 |
| NCT07525947Healthy Volunteers (HV) · United States | 1 | Recruiting | May 2027 | 40 |
| NCT07059312Healthy Volunteers · New Zealand | 1 | Completed | Oct 21, 2026 | 32 |
How it is read
Names in the registry
- “JADE101”, 4 entries
Codes read as this program: JADE101.
Conditions, from the studies’ own filings
- Glomerulonephritis, IGA, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.